Form 4: Aramark Director Heller Acquires Deferred Stock Units

Aramark Director Bridgette P Heller was granted 5,124 deferred stock units, vesting after the grant date of February 3, 2026, at a price of $38.06 per unit.

Summary

• Director Bridgette P Heller acquired 5,124 shares of Aramark Common Stock through a grant of deferred stock units.
• The transaction date for this acquisition is February 3, 2026, indicating a planned future grant.
• The acquisition price per unit was $38.06.
• Following this planned transaction, Heller will beneficially own 35,637.088 shares directly.
• These deferred stock units will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service.
• If vested, the units will be settled in shares of common stock on the first day of the seventh month after Director Heller's departure from the board.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard corporate governance practices and aligning director interests with long-term shareholder value, without indicating any immediate operational or financial shifts.

Positives

• Director Heller's beneficial ownership in Aramark will increase by 5,124 shares, further aligning her interests with shareholders.
• The grant of deferred stock units demonstrates continued commitment from the company to incentivize its directors through equity compensation.

Negatives

• This is a grant of deferred stock units, not an open market purchase, meaning there is no immediate cash investment by the director.
• The vesting and settlement of the units are subject to future conditions, including continued service and departure from the board.

Risks

• The ultimate value of the deferred stock units is subject to the future market price of Aramark common stock, which can fluctuate.
• Vesting is contingent on continued service, meaning the director could forfeit the units if service ceases prematurely.

Future Outlook

The deferred stock units are set to vest on the day prior to the first annual stockholders' meeting after the grant date (February 3, 2026), contingent on continued service. Settlement in shares will occur on the first day of the seventh month after the director's departure from the board.

Industry Context

StockSavvy.ai notes that equity grants to directors, such as deferred stock units, are a common practice across industries, including food services and facilities management, to align leadership interests with long-term shareholder value. This type of compensation is standard for companies like Aramark, which operates in a competitive service sector.

Comparison to Industry Standards

• Equity compensation for non-employee directors is a standard practice, comparable to peers like Compass Group PLC or Sodexo S.A., which also utilize stock-based awards to incentivize long-term commitment and performance.
• The specific grant size of 5,124 units at $38.06, totaling approximately $195,000, is within the typical range for annual director equity grants at companies of Aramark's market capitalization, reflecting competitive compensation practices.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with long-term shareholder value due to equity ownership.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• The deferred stock units will vest on the day prior to the first annual stockholders' meeting of Aramark occurring after February 3, 2026, subject to continued service.
• If vested, the units will be settled in shares of common stock on the first day of the seventh month after Director Heller's departure from the board.

Key Dates

Recommendation

This Form 4 reports a routine grant of deferred stock units to a director as part of their compensation package. It signifies standard corporate governance and aligns director interests with long-term shareholder value but does not provide new information that would warrant a change in investment thesis or an immediate 'buy' or 'sell' recommendation. It's an expected, non-event in terms of market impact.

Keywords

Aramark, ARMK, Form 4, Insider Transaction, Deferred Stock Units, Director Compensation, Equity Grant, Stock Ownership, 10b5-1 Plan